NRIX - Nurix Therapeutics, Inc.
17.08
0.590 3.454%
Share volume: 1,116,174
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$16.49
0.59
0.04%
Summary score
45%
Profitability
43%
Dept financing
24%
Liquidity
58%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.29%
Return on assets
-11.57%
Return on sales
-486.65%
Return on invested capital
13.73%
Total debt ratio
27.93%
Debt ratio change over timeo
-1.06%
Current Ratio
5.12%
Quick Ratio
4.39%
Cash Position Ratio
2.51%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-13.07%
Return on sales
-839.7%
Return on invested capital
0%
Total debt ratio
24.8%
Debt ratio change over timeo
0%
Current Ratio
6.3%
Quick Ratio
0%
Cash Position Ratio
1.42%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-14.54%
Return on sales
-1479.45%
Return on invested capital
0%
Total debt ratio
24.4%
Debt ratio change over time
0%
Current Ratio
6.01%
Quick Ratio
0%
Cash Position Ratio
0.77%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-94.07%
Return on assets
-97.93%
Return on sales
11.87%
Return on invested capital
66.36%
Total debt ratio
-105.58%
Debt ratio change over time
-1.06%
Current Ratio
-1.77%
Quick Ratio
-2.37%
Cash Position Ratio
-1.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NRIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -15.29% | 10.6% | 11.11% | 0% |
| Return on assets | -11.57% | 4.69% | 3.15% | 1.47% |
| Return on sales | -486.65% | 30.75% | 25.21% | 22.8% |
| Return on invested capital | 13.73% | 7.36% | 11.75% | 0% |
| Profitability | 25% | 87% | 84% | 26% |
| Total debt ratio | 27.93% | 80.39% | 59.47% | 95.26% |
| Debt ratio change over time | -1.06% | -25.01% | -101.26% | 0% |
| Dept financing | 7% | 21% | 16% | 50% |
| Current Ratio | 6.3% | 1.47% | 1.03% | 0.71% |
| Quick Ratio | 0% | 1.14% | 0.77% | 0.59% |
| Cash Position Ratio | 1.42% | 0.18% | 0.36% | 0.14% |
| Liquididy | 75% | 13% | 15% | 10% |
| Short-term ratios | NRIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -13.07% | 6.79% | 3.19% | 1.71% |
| Return on sales | -839.7% | 43.13% | 26.42% | 23.71% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 27% | 20% |
| Total debt ratio | 24.8% | 79.21% | 59.24% | 101.52% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 20% | 15% | 25% |
| Current Ratio | 6.3% | 1.47% | 1.03% | 0.71% |
| Quick Ratio | 0% | 1.14% | 0.77% | 0.59% |
| Cash Position Ratio | 1.42% | 0.18% | 0.36% | 0.14% |
| Liquididy | 50% | 34% | 27% | 18% |